Marker Therapeutics, Inc. (MRKR)
1.23
-0.02
(-1.60%)
USD |
NASDAQ |
Sep 03, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Research and Development Expense (Annual) : 11.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 11.80M |
| December 31, 2024 | 13.47M |
| December 31, 2023 | 10.42M |
| December 31, 2022 | 11.97M |
| December 31, 2021 | 27.79M |
| December 31, 2020 | 18.88M |
| December 31, 2019 | 12.76M |
| December 31, 2018 | 124.00M |
| December 31, 2017 | 5.251M |
| December 31, 2016 | 3.80M |
| December 31, 2015 | 1.711M |
| December 31, 2014 | 0.189M |
| December 31, 2013 | 0.6616M |
| December 31, 2012 | 1.057M |
| Date | Value |
|---|---|
| December 31, 2011 | 0.2037M |
| December 31, 2010 | 0.29M |
| December 31, 2009 | 0.093M |
| December 31, 2008 | 0.1823M |
| December 31, 2007 | 0.4256M |
| December 31, 2006 | 0.1732M |
| December 31, 2005 | 0.2484M |
| December 31, 2004 | 1.039M |
| December 31, 2003 | 1.727M |
| December 31, 2002 | 0.8336M |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 0.2949M |
| December 31, 1998 | 0.1033M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Krystal Biotech, Inc. | 52.32M |
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| SELLAS Life Sciences Group, Inc. | 16.02M |
| Rezolute, Inc. | 61.53M |
| ADMA Biologics, Inc. | 4.762M |